SCHEMBL5582523

SCHEMBL5582523

CC1=C(CN2CCN(C)CC2)CCc2cc(NC(=O)c3ccc(-c4ccc(F)cc4)cc3)ccc21

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 8/20 0.55
HTR2C P28335 5/20 0.55
LCK P06239 3/20 0.47
CSF1R P07333 3/20 0.47
MAPK14 Q16539 2/20 0.47
BTK Q06187 1/20 0.47
EGFR P00533 1/20 0.47
KDR P35968 1/20 0.47
ERBB4 Q15303 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
NPC1 O15118 1/20 0.47
TP53 P04637 1/20 0.47
NFKB1 P19838 1/20 0.47
RAB9A P51151 1/20 0.47
NFKB2 Q00653 1/20 0.47
RELA Q04206 1/20 0.47
HTR1F P30939 2/20 0.46
HTR1A P08908 1/20 0.46
HTR1D P28221 1/20 0.46
HTR1B P28222 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5582714 0.93 MCHR1 (0.64) MCHR1HTR2CMAPK14SMN1; SMN2NPC1
SCHEMBL5582939 0.92 MCHR1 (0.57) MCHR1HTR2CLCKCSF1RMAPK14
SCHEMBL5582598 0.90 MCHR1 (0.66) MCHR1HTR2CLCKCSF1RMAPK14
SCHEMBL5582590 0.89 MCHR1 (0.58) MCHR1MAPK14NPC1RAB9AABL1
SCHEMBL5582969 0.84 MCHR1 (0.63) MCHR1HTR2C
SCHEMBL5582952 0.84 MCHR1 (0.61) MCHR1HTR2CSMN1; SMN2
SCHEMBL5582730 0.83 MCHR1 (0.64) MCHR1HTR2CSMN1; SMN2
SCHEMBL5583099 0.82 MCHR1 (0.67) MCHR1HTR2CMAPK14RAB9A
SCHEMBL5582779 0.82 MCHR1 (0.56) MCHR1HTR2CLCKCSF1RMAPK14
SCHEMBL5583052 0.81 MCHR1 (0.56) MCHR1HTR2CLCKCSF1RMAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7115750-B1 Melanin concentrating hormone antagonist TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-10-03 US claimed
US-20070173498-A1 Melanin concentrating hormone antagonist KATO KANEYOSHI 2007-07-26 US disclosed
US-20070173498-A1 Melanin concentrating hormone antagonist KATO KANEYOSHI 2007-07-26 US disclosed
US-20070173498-A1 Melanin concentrating hormone antagonist KATO KANEYOSHI 2007-07-26 US disclosed
US-7115750-B1 Melanin concentrating hormone antagonist TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-10-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070173498-A1 Melanin concentrating hormone antagonist MC1R, MCHR1, MCHR2 MCHR1 2/4885HTR2C 195/4885LCK 4783/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.